Other OTC Pharmaceuticals - Russia

  • Russia
  • In Russia, the revenue generated in the Other OTC Pharmaceuticals market in 2024 amounts to US$1.67bn.
  • It is projected to experience an annual growth rate of 0.94% (CAGR 2024-2029).
  • When compared globally, the in the United States leads in revenue generation with US$7,171.00m in 2024.
  • In terms of per capita revenues, each person in Russia generates US$11.61 in 2024.
  • Russia's OTC Pharmaceuticals market is seeing a surge in demand for herbal remedies and traditional medicines.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Russia is experiencing significant growth due to several key factors.

Customer preferences:
Russian consumers are increasingly turning to over-the-counter (OTC) pharmaceuticals for their healthcare needs. This shift in preference can be attributed to several factors. Firstly, OTC medications are easily accessible and do not require a prescription, allowing consumers to quickly and conveniently address their health concerns. Additionally, the affordability of OTC drugs compared to prescription medications is appealing to cost-conscious consumers. Furthermore, the growing awareness and acceptance of self-medication practices among the Russian population have also contributed to the increased demand for OTC pharmaceuticals.

Trends in the market:
One of the major trends in the Other OTC Pharmaceuticals market in Russia is the growing demand for vitamins and dietary supplements. Russian consumers are becoming increasingly health-conscious and are actively seeking ways to improve their overall well-being. This has led to a surge in the consumption of vitamins and dietary supplements, which are perceived as natural and safe alternatives to traditional pharmaceuticals. Additionally, the aging population in Russia is driving the demand for OTC medications that address age-related health issues, such as joint pain and cardiovascular health.Another trend in the market is the rising popularity of herbal and natural remedies. Russian consumers are showing a preference for products that are perceived as more natural and holistic. This trend is driven by a growing awareness of the potential side effects and long-term risks associated with synthetic pharmaceuticals. As a result, there is an increasing demand for OTC products that are derived from natural sources, such as herbal extracts and plant-based ingredients.

Local special circumstances:
Russia has a unique healthcare system that influences the development of the Other OTC Pharmaceuticals market. The country has a high level of self-medication practices, with many consumers relying on OTC drugs for minor ailments and common health issues. This cultural norm has created a favorable environment for the growth of the OTC pharmaceutical market in Russia. Additionally, the widespread availability of OTC medications in pharmacies and retail outlets across the country further contributes to the market's expansion.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals market in Russia is also influenced by macroeconomic factors. Russia has experienced steady economic growth in recent years, which has resulted in an increase in disposable income levels among consumers. This rise in purchasing power has enabled more individuals to afford OTC medications, driving the demand for these products. Furthermore, the government's efforts to improve healthcare accessibility and affordability have also contributed to the growth of the OTC pharmaceutical market in Russia.In conclusion, the Other OTC Pharmaceuticals market in Russia is witnessing significant growth due to changing customer preferences, including the demand for vitamins and dietary supplements and the popularity of herbal and natural remedies. The local special circumstances, such as the prevalence of self-medication practices and the availability of OTC drugs, further contribute to the market's expansion. Additionally, underlying macroeconomic factors, such as increasing disposable income levels and government initiatives, play a role in driving the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)